he United States Bleeding Disorder Testing Market Size is anticipated to exceed USD 45.3 Million by 2033, Growing at a CAGR of 6.92% from 2023 to 2033. The growing innovative product launches and growing implementation of nanomaterials & artificial intelligence in blood disorders testing are driving the growth of the bleeding disorder testing market in the US.